isocitric acid has been researched along with Syndrome in 1 studies
isocitric acid: RN given refers to unlabeled parent cpd
isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group.
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martelli, MP | 1 |
| Martino, G | 1 |
| Cardinali, V | 1 |
| Falini, B | 1 |
| Martinelli, G | 1 |
| Cerchione, C | 1 |
1 review available for isocitric acid and Syndrome
| Article | Year |
|---|---|
Enasidenib and ivosidenib in AML.
Topics: Aminopyridines; Antineoplastic Agents; Cell Differentiation; Clinical Trials as Topic; Glutarates; G | 2020 |